Acelrx Pharmaceuticals reported $-8672000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acelrx Pharmaceuticals ACRX:US $ -8672000 323K
Baxter International BAX:US $ 432M 99M
Becton, Dickinson and BDX:US $ 648M 157M
Cara Therapeutics CARA:US $ -4472000 23.44M
Intra Cellular Therapies ITCI:US $ -87923000 15.26M
Johnson & Johnson JNJ:US $ 6941M 599M
Pain Therapeutics PTIE:US $ -19917000 2.1M
Pfizer PFE:US $ 12099M 2104M
Smiths SMIN:LN 20.7B 4.4B
Teva Pharmaceutical TEVA:IT 734M 55M
Xeris Pharmaceuticals Inc XERS:US $ -18916000 158K